Evidence map›Paper›PMID 30862949›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2019

Correction: JHU-083 selectively blocks glutaminase activity in brain CD11b

Xiaolei Zhu, Michael T Nedelcovych, Ajit G Thomas, Yuto Hasegawa, Aisa Moreno-Megui, Wade Coomer, Varun Vohra, Atsushi Saito, Gabriel Perez, Ying Wu and 8 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Xiaolei ZhuDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Michael T NedelcovychJohns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ajit G ThomasJohns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Yuto HasegawaDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Aisa Moreno-MeguiDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Wade CoomerDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Varun VohraDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Atsushi SaitoDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gabriel PerezDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Ying WuJohns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jesse AltJohns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Eva PrchalovaJohns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Lukáš TenoraInstitute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic v.v.i., Prague, Czech Republic.
Pavel MajerInstitute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic v.v.i., Prague, Czech Republic.
Rana RaisJohns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Camilo RojasJohns Hopkins Drug Discovery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID http://orcid.org/0000-0002-4695-3048
Barbara S SlusherDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. bslusher@jhmi.edu.
Atsushi KamiyaDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. akamiya1@jhmi.edu.

Funding

Therapeutic CoreP30MH075673 · NIMH · JOHNS HOPKINS UNIVERSITY · PI Barbara Stauch Slusher · 2006 to 2026
$33.2M
Project 3P50MH094268 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SAWA, AKIRA · 2011 to 2020
$19.9M
Surrogate Marker CoreP01MH105280 · NIMH · JOHNS HOPKINS UNIVERSITY · PI HAUGHEY, NORMAN J, MCARTHUR, JUSTIN CHARLES. · 2015 to 2019
$6.5M
Molecular mechanism of astrocytic vulnerability to adolescent cannabis useR01DA041208 · NIDA · JOHNS HOPKINS UNIVERSITY · PI KAMIYA, ATSUSHI, PLETNIKOV, MIKHAIL V · 2016 to 2020
$2.9M
Translational Research in Neuro-AIDS and Mental HealthR25MH080661 · NIMH · JOHNS HOPKINS UNIVERSITY · PI MCARTHUR, JUSTIN CHARLES. · 2007 to 2019
$2.9M
Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer TherapyR01CA193895 · NCI · JOHNS HOPKINS UNIVERSITY · PI HANES, JUSTIN S., LE, ANNE · 2016 to 2020
$2.1M
Dysregualtion of gliotransmission in models of neuroHIVR01MH110246 · NIMH · JOHNS HOPKINS UNIVERSITY · PI HAUGHEY, NORMAN J · 2016 to 2020
$2.0M
Exploring depressive behavior using a natural product for novel drug targetsR21AT008547 · NCCIH · JOHNS HOPKINS UNIVERSITY · PI KAMIYA, ATSUSHI · 2014 to 2015
$439k
Brain and Behavior Research Foundation (Brain & Behavior Research Foundation) Young Investigator AwardNIMH NIH HHS P01 MH105280NIMH NIH HHS P30 MH075673NIMH NIH HHS P50 MH094268NIMH NIH HHS R01 MH110246NIMH NIH HHS R25 MH080661Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation) Postdoctoral Fellowship in Pharmacology/ToxicologyU.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA193895U.S. Department of Health & Human Services | NIH | National Center for Complementary and Integrative Health (NCCIH) R21AT008547U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) P30MH075673U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) P50MH094268U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) R01DA041208
6 · The paper itself

Abstract

During this process, we found that we need add the following sentence in the manuscript within the Acknowledgement section.

Identifiers

PMID30862949
PMCPMC6461747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.